Status:
UNKNOWN
Exploring the Effects of Genetic Variants and Inflammation on Vitamins Supplementation Treatment Outcomes in Epilepsy
Lead Sponsor:
National Cheng-Kung University Hospital
Conditions:
Epilepsy
Eligibility:
All Genders
20-65 years
Phase:
NA
Brief Summary
The management of patients with epilepsy is focused on controlling seizures, avoiding treatment side effects, and restoring quality of life. However, about 30% of people are antiepileptic drugs (AEDs)...
Detailed Description
In the current study, investigators will evaluate the association among the genetic polymorphisms, epilepsy, and multi-vitamins supplementation from Taiwan Biobank and will further investigate potenti...
Eligibility Criteria
Inclusion
- Diagnostic criteria of epilepsy
- Receive anti-epileptic drugs (AEDs)
Exclusion
- Have an organic mental disorder, mental retardation, dementia, or other diagnosed neurological illness
- Have a surgical condition or a major physical illness
- Pregnant or breast-feeding
Key Trial Info
Start Date :
April 7 2015
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2021
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04488172
Start Date
April 7 2015
End Date
July 1 2021
Last Update
July 27 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Cheng Kung University (NCKU) Hospital
Tainan, Taiwan